S. Karakas

发表

Changes in plasma metabolites and glucose homeostasis during omega-3 polyunsaturated fatty acid supplementation in women with polycystic ovary syndrome

O. Fiehn, T. Kind, B. Perroud, 2016, BBA clinical.

Determinants of Impaired Fasting Glucose Versus Glucose Intolerance in Polycystic Ovary Syndrome

A. Duleba, Kyoungmi Kim, S. Karakas, 2010, Diabetes Care.

Lean mass and insulin resistance in women with polycystic ovary syndrome.

K. Comerford, Kyoungmi Kim, S. Karakas, 2012, Metabolism: clinical and experimental.

New biomarkers for diagnosis and management of polycystic ovary syndrome.

S. Karakas, 2017, Clinica chimica acta; international journal of clinical chemistry.

The Beneficial Effects α‐Cyclodextrin on Blood Lipids and Weight Loss in Healthy Humans

K. Comerford, K. Jen, J. D. Artiss, 2011, Obesity.

NASH in Nondiabetic Endocrine Disorders.

Wei Yang, S. Sarkar, S. Karakas, 2018, Metabolic syndrome and related disorders.

Free fatty acid binding protein-4 and retinol binding protein-4 in polycystic ovary syndrome: response to simvastatin and metformin therapies

A. Duleba, R. Spaczyński, L. Pawelczyk, 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Glucose-lowering effect of whey protein depends upon clinical characteristics of patients with type 2 diabetes

David M. Rocke, S. Karakas, R. Almario, 2017, BMJ Open Diabetes Research & Care.

Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome

Wei Zhang, L. Berglund, P. Kaur, 2016, Clinical endocrinology.

Lignan Content of the Flaxseed Influences Its Biological Effects in Healthy Men and Women

S. Karakas, R. Almario, 2013, Journal of the American College of Nutrition.

Boron in Human Health: Evidence for Dietary Recommendations and Public Policies

S. Karakas, S. Meacham, A. Wallace, 2010 .

Utility of hemoglobin-A1C in nondiabetic women with polycystic ovary syndrome.

K. Comerford, K. Kallail, S. Karakas, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Roles of Circulating WNT-Signaling Proteins and WNT-Inhibitors in Human Adiposity, Insulin Resistance, Insulin Secretion, and Inflammation

S. Karakas, R. Almario, S. E. Karakas, 2014, Hormone and Metabolic Research.

Refractory AIDS cholangiopathy: metabolic complications and the role of plasmapheresis.

R. Pollard, S. Karakas, M. E. Allen, 2013, AIDS.

Introduction to Polycystic Ovary Syndrome

S. Karakas, 2022, A Case-Based Guide to Clinical Endocrinology.

Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome.

Kyoungmi Kim, S. Karakas, R. Almario, 2011, Metabolism: clinical and experimental.

Metabolic and Endocrine Effects of Long Chain vs. Essential Omega-3 Polyunsaturated Fatty Acids in Polycystic Ovary Syndrome

S. Karakas, R. Almario, W. Buchan, 2011 .

Differential effects of walnuts vs almonds on improving metabolic and endocrine parameters in PCOS

S. Karakas, R. Almario, K. Kim, 2011, European Journal of Clinical Nutrition.

(-)-Epicatechin protects the intestinal barrier from high fat diet-induced permeabilization: Implications for steatosis and insulin resistance

F. Haj, K. Kalanetra, P. Oteiza, 2017, Redox biology.

In polycystic ovary syndrome, adrenal steroids are regulated differently in the morning versus in response to nutrient intake.

N. Keim, Kyoungmi Kim, W. Horn, 2010, Fertility and sterility.

New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men.

P. Surampudi, S. Karakas, Prasanth N Surampudi, 2018, Advances in clinical chemistry.

Anti-Mullerian Hormone-Based Phenotyping Identifies Subgroups of Women with Polycystic Ovary Syndrome with Differing Clinical and Biochemical Characteristics

S. Krishnan, S. Karakas, Minhthao Thi Nguyen, 2023, Diagnostics.

Whey protein supplementation does not alter plasma branched-chained amino acid profiles but results in unique metabolomics patterns in obese women enrolled in an 8-week weight loss trial.

O. Fiehn, S. Adams, T. Knotts, 2015, The Journal of nutrition.

In search of the "LINK": Acute Phase Serum Amyloid A.

S. Karakas, R. Mortada, Clinical Fellow, 2011, Atherosclerosis.

Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers.

Kyoungmi Kim, S. Karakas, R. Almario, 2009, Metabolism: clinical and experimental.

Women Also Use 5α-Reductase Inhibitors.

S. Karakas, 2017, JAMA internal medicine.

SELF BLOOD GLUCOSE MONITORING UNDERESTIMATES HYPERGLYCEMIA AND HYPOGLYCEMIA AS COMPARED TO CONTINUOUS GLUCOSE MONITORING IN TYPE 1 AND TYPE 2 DIABETES.

S. Krishnan, C. Cox, S. Karakas, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Whey protein supplementation does not alter plasma branched-chained amino acid profiles but results in unique metabolomics patterns in obese women enrolled in an 8-week weight loss trial.

O. Fiehn, S. Adams, T. Knotts, 2015, The Journal of nutrition.

HbA1c in Patients with Polycystic Ovary Syndrome: A Potential Marker of Inflammation

K. Kallail, S. Karakas, F. Dong, 2015, Journal of reproduction & infertility.